Siddhant Kabra, a promoter group member of Eiko Lifesciences Limited, has acquired 71,000 equity shares via open market purchase, raising his total holding to 5.83% of the company’s equity. This increase reflects a strategic consolidation of promoter ownership, potentially indicating confidence in the company’s prospects. The total equity base remains unchanged, and the acquisition strengthens promoter control, which may positively influence shareholder sentiment.